|
|
Logo
Logo Logo

Category Archives: "Partners"

  1. Home
  2. Advocacy
  3. Page 4
Jul 08, 2020
WHO and AMA statement
Advocacy, CMSC PR, MS Community, Partners
"The Trump administration's official withdrawal from the World Health Organization (WHO) puts the health of our country at grave risk. As [...]
admin
Read More
...21
0
Jul 01, 2020
A letter from Lemtrada regarding its home phlebotomy partner, EMSI
INforMS, Partners
Good Day Lemtrada Patient – On July 3, 2020 Sanofi Genzyme was notified that our Lemtrada Home Phlebotomy Partner, Examination [...]
Elizabeth Porco
Read More
...15
0
Jun 04, 2020
Multiple sclerosis patients can benefit from expanded services from MSAA
Partners
In light of the COVID-19 pandemic and its impact on the MS community, please know the Multiple Sclerosis Association of American (MSAA) has [...]
Elizabeth Porco
Read More
...15
0
Jun 01, 2020
ZEPOSIA launch press release
Partners
Bristol Myers Squibb Announces Commercial Launch and Availability of ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of [...]
Elizabeth Porco
Read More
...16
0
May 27, 2020
Rebif® U.S. label includes pregnancy outcomes & lactation information
INforMS, Partners
- Label update is based on data from a large register-based study, as well as other published studies over several decades - Multiple [...]
Elizabeth Porco
Read More
...18
0
Apr 27, 2020
New 6-year data for Genentech’s Ocrevus (ocrelizumab) findings
Partners
New 6-Year Data for Genentech’s Ocrevus (ocrelizumab) Show Earlier Treatment Initiation Nearly Halves Risk of Needing Walking Aid in [...]
Elizabeth Porco
Read More
...14
0
Apr 02, 2020
Coronavirus and multiple sclerosis reporting database
CMSC PR, Partners
COViMS (COVID-19 Infections in MS & Related Diseases) is a joint effort of the Consortium of MS Centers (CMSC) and the National MS [...]
Elizabeth Porco
Read More
...20
0
Mar 26, 2020
FDA approves Zeposia (Ozanimod), oral therapy for all with relapsing multiple sclerosis
INforMS, Partners
The U.S. Food and Drug Administration (FDA) has approved Zeposia (ozanimod) oral capsules to treat adults with relapsing forms [...]
Elizabeth Porco
Read More
...16
0
Mar 10, 2020
CMSC update on COVID-19: NMSS National Medical Advisory Committee recommendations
CMSC PR, Partners
The Centers for Disease Control and Prevention (CDC) are following the outbreak of coronavirus (COVID-19), which causes a respiratory [...]
Elizabeth Porco
Read More
...18
0
Mar 03, 2020
Multiple sclerosis and COVID-19 registry
CMSC PR, Partners
Dear Colleagues and Clients:  We know you are interested in what happens to people with MS and related diseases who develop [...]
Elizabeth Porco
Read More
...19
0
  • (201) 487-1050
  • 3 University Plz Dr Ste 116, Hackensack, NJ 07601
  • info@mscare.org

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us
I have a question about
First
Last